Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese Patients With Early Breast Cancer Undergoing Breast-conserving Surgery

NCT03606616 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT03606616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03606616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese Patients With Early Breast Cancer Undergoing Breast-conserving Surgery
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Completed
Start date
November 1, 2014
Completion date
November 30, 2019
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, local recurrence of malignant tumor of breast, sentinel lymph node